Phoenix Financial Ltd. Makes New $210,000 Investment in Kenvue Inc. $KVUE

Phoenix Financial Ltd. acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) during the second quarter, HoldingsChannel.com reports. The fund acquired 10,021 shares of the company’s stock, valued at approximately $210,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Evergreen Wealth Solutions LLC lifted its position in Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after acquiring an additional 432 shares in the last quarter. Scott & Selber Inc. lifted its position in shares of Kenvue by 0.4% during the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock worth $2,557,000 after purchasing an additional 475 shares in the last quarter. Wealth Alliance LLC lifted its position in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after purchasing an additional 486 shares in the last quarter. Everett Harris & Co. CA lifted its position in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after purchasing an additional 500 shares in the last quarter. Finally, Proffitt & Goodson Inc. lifted its position in shares of Kenvue by 8.2% during the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after purchasing an additional 517 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

KVUE has been the topic of several recent analyst reports. Redburn Partners set a $22.00 price target on Kenvue in a research note on Friday, September 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Barclays cut their target price on Kenvue from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. cut their price target on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $21.18.

Kenvue Trading Down 0.8%

Shares of NYSE KVUE opened at $15.07 on Friday. The stock’s 50 day moving average price is $18.03 and its two-hundred day moving average price is $20.84. Kenvue Inc. has a 52-week low of $14.05 and a 52-week high of $25.17. The stock has a market capitalization of $28.91 billion, a P/E ratio of 20.36, a PEG ratio of 2.19 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business’s revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.5%. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue’s dividend payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.